AstraZeneca plc (ADR) (NYSE:AZN) As I noted 10 weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing since 1991 thanks to access to more effective medications and ...

Is AstraZeneca plc (LON: AZN) a solid pick for dividend growth? Dividend income accounts for around two-thirds of total returns, the actual rate of return taking into account both capital and income appreciation.

Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced the results from a 12-month sub-group analysis of a National Institutes of Health (NIH), open-label, long-term research study of metreleptin, an investigational ...

The shares of AstraZeneca plc (LON:AZN) pass a large number of popular investment screens. Does this mean that they are set to rocket?

LONDON - AstraZeneca Plc, the U.K.'s second-biggest pharmaceutical company, reported first-quarter sales that missed analysts' estimates as some of its best-selling medicines faced generic competition.

Unilever plc (LON: ULVR), AstraZeneca plc (LON: AZN) and Kier Group plc (LON: KIE) are all falling. The FTSE 100 dipped early this morning, despite the news that the UK economy has so far avoided a triple-dip recession by growing 0.3% in the first ...

AstraZeneca plc (LON:AZN) shares are trading 0.97 pct higher than seen at Friday's close; AZN is at 3,373.98 at 9:50 in London.

AstraZeneca and BIND Therapeutics announced today that they have entered into a strategic collaboration to develop and commercialise an Accurin�, a targeted and programmable cancer nanomedicine from BIND's Medicinal Nanoengineering platform, ...

AstraZeneca plc (LON: AZN), Telecom Plus PLC (LON: TEP) and Barratt Developments Plc (LON: BDEV) are flying. It's little more than a month since the FTSE 100 set a new five-year record of 6,534 points, on 12 March.

Director Deals - AstraZeneca PLC (AZN). 29 April 2013 | 15:15pm. StockMarketWire.com - Simon Lowth, Financial Director, sold post-exercise 54,561 shares in the company on the 26th April 2013 at a price of 3316.00p.